Menu

asx announcements (2014)

23/12/2014 RNO: Australian Pharmacy Sales Force Appointed for Mute
22/12/2014 RNO: R&D Tax Incentive of $570K Received to Support Development
08/12/2014 RNO: Rhinomed Releases Mute™ Technology on www.mutesnoring.com
03/12/2014 RNO: Rhinomed’s New Snoring Product Mute Receives Major Regulatory Approvals
02/12/2014 RNO: Rhinomed’s Mute Successful in Demonstrating Efficacy and Benefit in Snoring Trial
11/11/2014 RNO: Turbine Achieves CE Mark Registration
29/10/2014 RNO: Chairman’s Address to Shareholders – 2014 AGM
29/10/2014 RNO: Rhinomed Share Purchase Plan Results
29/10/2014 RNO: Quarterly Report
27/10/2014 RNO: Rhinomed Secures South African Distribution for Turbine
08/10/2014 RNO: Rhinomed Secures Turbine Distribution in Thailand
08/10/2014 RNO: Rhinomed Secures Distribution for Turbine in Malaysia, Singapore and Indonesia
26/09/2014 RNO: Rhinomed Secures Colombian Distribution for Turbine
22/09/2014 RNO: Rhinomed Secures Japanese Distribution for Turbine
16/09/2014 RNO: Turbine Interbike Update
09/09/2014 RNO: Share Purchase Plan Offer Document
05/09/2014 RNO: Completion of Placement
01/09/2014 RNO: Fully Underwritten $5 Million Capital Raise
21/08/2014 Rhinomed Appoints Turbine Distributor in Israel
21/08/2014 Rhinomed Appoints BikeBox as Turbine Distributor for Australian Cycling Industry
21/07/2014 Bioshares 2014
17/07/2014 TURBINE Granted FDA Registration
10/07/2014 RNO: Lead Turbine® Technology Records Strong Sales Growth
06/06/2014 Growth in Subscriber Base & Retail Outlets
14/05/2014 TURBINE™ User Trial Power Results Presentation
14/05/2014 TURBINE™ User Trial Power Results Investor Conference Call
13/05/2014 TURBINE Ridewiser Trial
09/05/2014 Green Jersey Winner Baden Cooke joins team Turbine
29/04/2014 Turbine Continues to Receive Strong Product Reviews
23/04/2014 Autumn (April) Newsletter
11/04/2014 Results of General Meeting
24/03/2014 Change of Director’s Interest Notice
17/03/2014 TURBINE™ Partners Ironman Asia-Pacific Championships Melbourne 2014
17/03/2014  Director Resignation
11/03/2014  Notice of General Meeting
28/02/2014  RNO Receives $388k R&D Tax Incentive to Support BreatheAssist Development
20/02/2014  RNO Raises $2.5million to Accelerate Drug Delivery Program
 18/02/2014  Shareholder Update February 2014
14/02/2014  Rhinomed Targets Acute Migraine Market with Drug Delivery Program
12/02/2014  Rhinomed Strengthens Board To Drive Growth
07/02/2014  US Market Research confirms Signifcant Opportunity for Turbine
31/01/2014  Appendix 4C Quarterly Report
31/01/2014  Tour Down Under Turbine Release
17/01/2014  Summer (January) Newsletter